Tilray (NASDAQ:TLRY) Shares Up 0.8%

Tilray Inc (NASDAQ:TLRY)’s stock price traded up 0.8% on Friday . The stock traded as high as $1.87 and last traded at $1.85. 4,100,284 shares changed hands during trading, a decline of 87% from the average session volume of 30,506,510 shares. The stock had previously closed at $1.83.

Analyst Ratings Changes

TLRY has been the topic of a number of recent analyst reports. Canaccord Genuity Group lowered their price target on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. CIBC dropped their target price on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Finally, Alliance Global Partners upped their price target on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th.

Tilray Stock Performance

The firm has a market cap of $1.42 billion, a price-to-earnings ratio of -4.19 and a beta of 2.36. The company’s 50-day moving average price is $2.05 and its 200-day moving average price is $1.96. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11.

Institutional Investors Weigh In On Tilray

Several institutional investors have recently bought and sold shares of the company. Clear Street Markets LLC purchased a new stake in Tilray during the 3rd quarter worth approximately $25,000. Gainplan LLC purchased a new stake in Tilray during the 4th quarter worth approximately $28,000. Simplicity Wealth LLC purchased a new stake in Tilray during the 1st quarter worth approximately $28,000. RPO LLC purchased a new stake in Tilray during the 4th quarter worth approximately $28,000. Finally, Great Valley Advisor Group Inc. purchased a new stake in Tilray during the 3rd quarter worth approximately $29,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.